NEW YORK, Nov. 2 — Genicon Sciences has closed a deal to allow the Genomics Institute of the Novartis Research Foundation to use its proprietary Resonance Light Scattering technology, according to Genicon. 

The partners will cooperatively develop and commercialize the technology, which Genicon has designed for stable, highly sensitive signal generation and detection in a range of molecular assays.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.

NPR reports that government and private insurers are being slow to cover recently approved CAR-T cell therapies.

CNBC reports that there are thousands of genetic tests available for consumers to chose between.

In Nature this week: genomic analysis of ducks, whole-genome doubling among tumor samples, and more.